COVID-19 Vaccines: Current Conditions and Future Prospects
| Autor: | Janice Kim, Tarek Zieneldien, Jessica Cao, Chuanhai Cao |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
General Immunology and Microbiology Coronavirus disease 2019 (COVID-19) QH301-705.5 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike Protein COVID-19 Review adenovirus Biology lipid nanoparticles spike protein General Biochemistry Genetics and Molecular Biology DNA vaccination angiotensin-converting enzyme 2 (ACE2) mRNA vaccine Risk analysis (engineering) Biology (General) General Agricultural and Biological Sciences |
| Zdroj: | Biology Biology, Vol 10, Iss 960, p 960 (2021) |
| ISSN: | 2079-7737 |
| Popis: | Simple Summary The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first encountered in December of 2019 in Wuhan, China. As of now, there have been over 200 million infections and 4 million deaths attributed to the virus. Due to this, it has been a priority to find an effective preventative measure, and numerous vaccines have been developed. Although the developed vaccines share the target of blocking viral entry by the spike protein, their pharmacology and efficacy differs. As such, the mechanism of action and the elicited immune response of the most common COVID-19 vaccines have been compared to help determine which vaccine is most efficacious and is best suited to prevent reinfection and address viral mutations. Abstract It has been over a year since SARS-CoV-2 was first reported in December of 2019 in Wuhan, China. To curb the spread of the virus, many therapies and cures have been tested and developed, most notably mRNA and DNA vaccines. Federal health agencies (CDC, FDA) have approved emergency usage of these S gene-based vaccines with the intention of minimizing any further loss of lives and infections. It is crucial to assess which vaccines are the most efficacious by examining their effects on the immune system, and by providing considerations for new technological vaccine strategies in the future. This paper provides an overview of the current SARS-CoV-2 vaccines with their mechanisms of action, current technologies utilized in manufacturing of the vaccines, and limitations in this new field with emerging data. Although the most popular COVID-19 vaccines have been proven effective, time will be the main factor in dictating which vaccine will be able to best address mutations and future infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|